{
  "meta": {
    "timestamp": "2025-01-06T08:42:26.360257",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "OraSure Technologies Inc",
      "symbol": "OSUR",
      "analysis": {
        "historical": {
          "risk_score": 60,
          "key_risks": [
            "Post-Pandemic Revenue Decline",
            "Regulatory Hurdles",
            "Supply Chain Vulnerabilities",
            "Intense Competition",
            "Ethical and Accessibility Concerns"
          ],
          "controversies": [
            "Rapid Test Accuracy",
            "Ethical Concerns in Resource-Limited Settings"
          ],
          "environmental_issues": [],
          "social_issues": [
            "HIV Testing Advocacy",
            "Accessibility of Rapid Diagnostic Tests"
          ],
          "governance_issues": [
            "Regulatory Compliance",
            "Supply Chain and Labor Risks"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "OraSure in 2025: Changes, challenges and silver linings",
              "snippet": "BETHLEHEM, Pa.- OraSure Technologies will lean into innovation in the new year, as it continues to chart its post-pandemic future. President and CEO Carrie Eglinton Manner, who stepped into the ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:05.803148+00:00",
              "published_date": null,
              "source_hash": "caef4ae6b9de98d68a562b28b5e90e99"
            },
            {
              "url": "",
              "title": "January 12, 2023 220 East First Street - U.S. Food and Drug Administration",
              "snippet": "Page 2 - Tiffany Miller, OraSure Technologies, Inc. November 1, 2021. 4. and January 27, 2022. 5. In addition, based on your requests, FDA granted an update to the authorized labeling on August ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory challenges FDA",
              "retrieved_at": "2025-01-06T15:41:57.753604+00:00",
              "published_date": null,
              "source_hash": "1de8ca4a101f201149eb157a3b2552d2"
            },
            {
              "url": "",
              "title": "January 27, 2022 OraSure Technologies, Inc. 220 East First Street ...",
              "snippet": "VP Regulatory Affairs . OraSure Technologies, Inc. 220 East First Street . Bethlehem, PA 18015 . Device: InteliSwab COVID-19 Rapid Test Pro ... request the Food and Drug Administration (FDA) issued an",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory challenges FDA",
              "retrieved_at": "2025-01-06T15:41:57.753624+00:00",
              "published_date": null,
              "source_hash": "d7e921506e9fecf4f8ce883e501e0663"
            },
            {
              "url": "",
              "title": "January 17, 2023 Tiffany Miller OraSure Technologies, Inc. 220 East ...",
              "snippet": "January 17, 2023 . Tiffany Miller . VP Regulatory Affairs . OraSure Technologies, Inc. 220 East First Street . Bethlehem, PA 18015 . Device: InteliSwab COVID-19 Rapid Test Rx",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory challenges FDA",
              "retrieved_at": "2025-01-06T15:41:57.753638+00:00",
              "published_date": null,
              "source_hash": "11042c12860539912348aac41d37af94"
            },
            {
              "url": "",
              "title": "OraSure Technologies Receives General Clearance for its ORAcollect\u00ae\u2022Dx ...",
              "snippet": "OraSure Technologies, Inc. FDA Clearance Received Through Partnership with Grifols to Support Screening for Risk of Alpha 1 - Antripsyn Deficiency (Alpha-1) in U.S. Adult Population.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory challenges FDA",
              "retrieved_at": "2025-01-06T15:41:57.753651+00:00",
              "published_date": null,
              "source_hash": "9b9503f2882eafd02b7513e6b8ad73a3"
            },
            {
              "url": "",
              "title": "Investor Presentation - orasure.gcs-web.com",
              "snippet": "applications for existing products; ability to comply with applicable regulatory requirements; ability to effectively resolve warning letters, audit observations and other findings or comments from the U.S. Food and Drug",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory challenges FDA",
              "retrieved_at": "2025-01-06T15:41:57.753671+00:00",
              "published_date": null,
              "source_hash": "72c246dabf9e93ad5ec0aed3546e133c"
            },
            {
              "url": "",
              "title": "Class 3 Device Recall Orasure Technologies Interept - accessdata.fda.gov",
              "snippet": "Orasure Technologies Interept Benzodiazopene Miro-Plate EIA-Benzo EIA 5plate Matrix Oral Fluid Coated Micro-Plate-IVD Immunoassay for Benzodiazepines, Product Number: 1110IB: Code Information: Lot Number: 6673115 Exp. Date:03/31/2020 UDI: 608337000238: Recalling Firm/ Manufacturer: OraSure Technologies, Inc. 220 E 1st St Bethlehem PA 18015-1360",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory challenges FDA",
              "retrieved_at": "2025-01-06T15:41:57.753684+00:00",
              "published_date": null,
              "source_hash": "fd6732348ea49bfe3416eddb9fafa0c6"
            },
            {
              "url": "",
              "title": "Files taken from Orasure systems in cybersecurity incident",
              "snippet": "While Orasure believes it has contained the incident, it was still assessing \"what, if any, regulatory and legal notifications are required.\" The findings of an investigation into the incident and whether personal data was accessed will inform the next steps. Orasure described its cybersecurity approach in a March annual financial filing ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory challenges FDA",
              "retrieved_at": "2025-01-06T15:41:57.753698+00:00",
              "published_date": null,
              "source_hash": "decb6b69e80cff53d95a5649f507e0fd"
            },
            {
              "url": "",
              "title": "After 55% Revenue Drop, OraSure Bets on Proteomics and International ...",
              "snippet": "After 55% Revenue Drop, OraSure Bets on Proteomics and International Growth January 05, 2025 OSUR Q3 2024 Summary. OraSure Technologies reported a challenging third quarter, with revenues declining 55% year-over-year to $39.9 million, largely due to the completion of a major COVID-19 contract and declining revenues in other areas.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory challenges FDA",
              "retrieved_at": "2025-01-06T15:41:57.753712+00:00",
              "published_date": null,
              "source_hash": "575b5d716c444beb74dc230fae798b72"
            },
            {
              "url": "",
              "title": "Premarket Approval (PMA) - accessdata.fda.gov",
              "snippet": "Orasure HIV-1 Oral Specimen Collection Device: ... point of care hiv serology diagnostic and/or supplemental test: Regulation Number: 866.3956: Applicant: OraSure Technologies, Inc: Beaverton , OR 97005 PMA Number: BP910001: Supplement Number: S034: Date Received ... MD 20993 Ph. 1-888-INFO-FDA (1-888-463-6332) Contact FDA. For Government; For ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory challenges FDA",
              "retrieved_at": "2025-01-06T15:41:57.753724+00:00",
              "published_date": null,
              "source_hash": "8cfe9a6434744d88deff9521ecbc1a1f"
            },
            {
              "url": "",
              "title": "OraSure in 2025: Changes, challenges and silver linings",
              "snippet": "President and CEO Carrie Eglinton Manner spoke to 69 News about what's on the horizon for the Bethlehem-based maker of medical diagnostic testing and collection devices.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:08.257610+00:00",
              "published_date": "2025-01-02T15:02:00+00:00",
              "source_hash": "f750b86210a4f65bceec4fce2b72055f"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Expands Diagnostic Portfolio with Acquisition of Sherlock Biosciences, Inc.",
              "snippet": "OraSure Technologies, Inc. has announced the acquisition ... and is expected to be submitted to the FDA by the end of 2025 for review. Subject to regulatory approvals, revenue from Sherlock ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory challenges FDA",
              "retrieved_at": "2025-01-06T15:42:00.144014+00:00",
              "published_date": "2024-12-19T21:11:00+00:00",
              "source_hash": "4bff6f395f58310fa8c4b9fb295a5af2"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Receives $7.5 Million Award for Development of Rapid Antigen Test for Marburg Virus Disease",
              "snippet": "OraSure Technologies received a $7.5 million contract to develop a rapid antigen test for Marburg Virus Disease. OraSure Technologies, Inc. announced ... exposure to regulatory challenges, as ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory challenges FDA",
              "retrieved_at": "2025-01-06T15:42:00.144027+00:00",
              "published_date": "2024-12-02T12:11:00+00:00",
              "source_hash": "5dc086a2b6a3a9eb4b6120602762d8fe"
            },
            {
              "url": "",
              "title": "OraSure Technologies Acquires Sherlock Biosciences",
              "snippet": "Dec. 19, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (\"OTI ... expected to be submitted to the FDA by the end of 2025 for review. Subject to regulatory approvals, revenue from ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory challenges FDA",
              "retrieved_at": "2025-01-06T15:42:00.144034+00:00",
              "published_date": "2024-12-19T21:10:00+00:00",
              "source_hash": "db1dfddf86b00bd4cc575eb66eeb5963"
            },
            {
              "url": "",
              "title": "OraSure acquires maker of over-the-counter STI tests",
              "snippet": "OraSure Technologies, Inc. (\"OTI ... (NG,) subject to regulatory approvals. Sherlock's CT/NG self-test is in clinical studies and is expected to be submitted to the FDA by the end of ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc regulatory challenges FDA",
              "retrieved_at": "2025-01-06T15:42:00.144040+00:00",
              "published_date": "2024-12-20T00:00:00+00:00",
              "source_hash": "14726f5de3ee416d96715e790f293fd0"
            },
            {
              "url": "",
              "title": "Rapid Infectious Disease Products - orasure.com",
              "snippet": "Oraquick ADVANCE \u00ae HIV-1/2 Rapid Antibody Test. The OraQuick ADVANCE \u00ae Rapid HIV\u20111/2 Antibody Test is FDA\u2011approved for use with oral fluid, fingerstick or venous whole blood and plasma and delivers results with laboratory accuracy in 20 minutes. CDC guidelines call for routine testing in all healthcare settings to identify all HIV positive people and connect them to care.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:02.045627+00:00",
              "published_date": null,
              "source_hash": "351931c7b925fd759a719b270d611459"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. and should carefully review the InteliSwab ...",
              "snippet": "COVID-19 RAPID TEST RX . OraSure Technologies, Inc. January 17, 2023 ... accurate diagnosis via the InteliSwab\u00ae COVID-19 Rapid Test Rx. When diagnostic testing is negative, the possibility of a ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:02.045749+00:00",
              "published_date": null,
              "source_hash": "b5277d8a079367725f971acdbe153d1e"
            },
            {
              "url": "",
              "title": "OraSure InteliSwab\u2122 Rapid Antigen Test Performance with the ... - PubMed",
              "snippet": "The emergence of SARS-CoV-2 in the human population and the resulting COVID-19 pandemic have led to the development of various diagnostic tests. The OraSure InteliSwab \u2122 COVID-19 Rapid Test is a recently developed and FDA emergency use-authorized rapid antigen-detecting test that functions as a lateral flow device targeting the nucleocapsid ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:02.045768+00:00",
              "published_date": null,
              "source_hash": "7317f504d47cfb089106f9cba058cc05"
            },
            {
              "url": "",
              "title": "OraSure InteliSwab\u2122 Rapid Antigen Test Performance with the SARS-CoV-2 ...",
              "snippet": "The emergence of SARS-CoV-2 in the human population and the resulting COVID-19 pandemic have led to the development of various diagnostic tests. The OraSure InteliSwab \u2122 COVID-19 Rapid Test is a recently developed and FDA emergency use-authorized rapid antigen-detecting test that functions as a lateral flow device targeting the nucleocapsid ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:02.045783+00:00",
              "published_date": null,
              "source_hash": "0437eca157b0271c95030e9022120f49"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Home",
              "snippet": "OraSure Technologies is a global company that empowers the world to improve health and wellness by providing access to accurate, ... DNA Genotek, Inc., is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:02.045798+00:00",
              "published_date": null,
              "source_hash": "1b1a8c8d202a17e9d00fa2a5eeb93773"
            },
            {
              "url": "",
              "title": "SureQuick Syphilis Test - OraSure Technologies",
              "snippet": "Accurate & Reliable \u2022 Over 99.8% accurate: Sensitivity: 99.9% Specificity: 99.7% \u2022 Includes a control line to confirm the validity of the test. \u2022 Shelf life of 24 months from the date of manufacture \u2022 Utilizes recombinant Syphilis antigen and a double antigen test format to detect both IgG and IgM antibodies. Accessible",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:02.045813+00:00",
              "published_date": null,
              "source_hash": "04bc53cab43f875b047a2a9c0cf6ac4a"
            },
            {
              "url": "",
              "title": "(PDF) A Prospective Field Study to Evaluate the Performance and ...",
              "snippet": "The study objectives were to: (1) evaluate the oral fluid-based OraQuick\u00ae HIV Self-Test (HIV-ST) performance compared with. Background: Blood and oral fluid-based HIV self-tests are important for reaching the undiagnosed especially in key populations. The study objectives were to: (1) evaluate the oral fluid-based OraQuick\u00ae HIV Self-Test (HIV ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:02.045827+00:00",
              "published_date": null,
              "source_hash": "2f09097827092c46d12a425e543fbbe3"
            },
            {
              "url": "",
              "title": "Rapid hepatitis C test - OraQuick\u00ae - Orasure Technologies - MedicalExpo",
              "snippet": "Find out all of the information about the Orasure Technologies product: rapid hepatitis C test OraQuick\u00ae. ... Our simple platform enables healthcare providers to deliver an accurate diagnosis in 20 minutes. ... Rapid Results \u2022 Point-of-care-testing results in 20 minutes Laboratory Accuracy \u2022 Greater than 98% accurate \u2022 Tests for multiple ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:02.045841+00:00",
              "published_date": null,
              "source_hash": "757424a26b0175c53294076552ec2441"
            },
            {
              "url": "",
              "title": "Feasibility and Acceptability of HIV Self-Test Kit Distribution Through ...",
              "snippet": "Implementation Research Logic Model. Assessments. As described by Palinkas, et al., mixed-methods assessments were employed in this study to measure pilot intervention outcomes while simultaneously understanding the process from the perspectives of both MP staff and MP client implementers [].The number of MP clients who were approached and did not wish to participate in HIVST kit distribution ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:02.045854+00:00",
              "published_date": null,
              "source_hash": "01923e9dfded00595e7366ef7d8264e1"
            },
            {
              "url": "",
              "title": "OraSure in 2025: Changes, challenges and silver linings",
              "snippet": "Also, OraSure is now using packaging improvements- think less plastic and waste- it honed on the InteliSwab test on its OraQuick test. Financial outlook. OraSure's stock (NASDAQ: OSUR) finished ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:02.045867+00:00",
              "published_date": null,
              "source_hash": "6cadc40d0f43b2b0908a12388e08025c"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Expands Diagnostic Portfolio with Acquisition of Sherlock Biosciences, Inc.",
              "snippet": "OraSure Technologies acquires Sherlock Biosciences to enhance its diagnostic test portfolio, targeting sexually transmitted infections with rapid self-testing solutions. OraSure Technologies, Inc ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:04.315793+00:00",
              "published_date": "2024-12-19T21:11:00+00:00",
              "source_hash": "c8c3f741d9360f0477d4ac817bea2cf6"
            },
            {
              "url": "",
              "title": "OraSure Technologies Acquires Sherlock Biosciences",
              "snippet": "Dec. 19, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc ... lab-like accuracy in a format that expands access to diagnostic insights through convenient, effortless tests.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:04.315876+00:00",
              "published_date": "2024-12-19T21:10:00+00:00",
              "source_hash": "57b9b3bed0f85fd367c53a90d9fce802"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Receives $7.5 Million Award for Development of Rapid Antigen Test for Marburg Virus Disease",
              "snippet": "OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions, today announced that it received an award through the Rapid Response ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:04.315905+00:00",
              "published_date": "2024-12-02T12:11:00+00:00",
              "source_hash": "f2b6021f8551f964b119aef486c88d4d"
            },
            {
              "url": "",
              "title": "OraSure Technologies: Return To Profitability Is Uncertain",
              "snippet": "OraSure Technologies ... OSUR makes diagnostic health products. Other than the COVID swabs, their biggest product segments are \"Genomics\" and their OraQuick HIV test. These segments existed ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:04.315930+00:00",
              "published_date": "2024-12-19T05:59:00+00:00",
              "source_hash": "cddada0c979c7ceaa45c27de167472f3"
            },
            {
              "url": "",
              "title": "OraSure Technologies (NASDAQ:OSUR) Stock Rating Upgraded by StockNews.com",
              "snippet": "OraSure Technologies (NASDAQ:OSUR - Get Free Report) was upgraded by StockNews.com from a \"hold\" rating to a \"buy\" rating in a note issued to investors on Wednesday. OraSure Technologies Stock Down 1.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "retrieved_at": "2025-01-06T15:42:04.315953+00:00",
              "published_date": "2025-01-03T05:36:00+00:00",
              "source_hash": "d371f2e0fb9725ecace03c692f17a7f0"
            },
            {
              "url": "",
              "title": "Orasure Technologies : Management'S Discussion and Analysis of ...",
              "snippet": "OraSure Technologies, Inc. ... reliance on sole supply sources for critical products and components; ... COVID-related disruption in clinical and research work, particularly in the academic market, had reduced demand for our products in 2020 and early 2021, but demand levels started to return to normal in the second quarter of 2021. ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:05.803257+00:00",
              "published_date": null,
              "source_hash": "9f9cd6d8486bcf3056d601412ccd3b14"
            },
            {
              "url": "",
              "title": "ORASURE TECHNOLOGIES, INC. - MarketScreener",
              "snippet": "BETHLEHEM, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions, ... (\"COVID-19\") pandemic or other public health crises on the Company's business, supply chain, labor force, ability to successfully develop new products, ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:05.803273+00:00",
              "published_date": null,
              "source_hash": "7cde9d345a73f8546e30a1ef851654e3"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Expands Diagnostic Portfolio with ...",
              "snippet": "About OraSure Technologies, Inc. ... (\"COVID-19\") pandemic on the Company's business, supply chain, labor force, ability to successfully develop new products, validate the expanded use of ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:05.803285+00:00",
              "published_date": null,
              "source_hash": "d309faa65b3d4c1d15e9e1a70c8f7467"
            },
            {
              "url": "",
              "title": "10-K - SEC.gov",
              "snippet": "the impact of COVID-19 on our supply chain; ... The overall goal of OraSure Technologies, Inc. (\"OraSure\" or \"the Company\") is to empower the global community to improve health and wellness by providing access to accurate essential information through effortless tests, collection kits and services. ... the ease of maintaining a chain-of ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:05.803295+00:00",
              "published_date": null,
              "source_hash": "6ef807103c88e86e16bcbff9ca52e808"
            },
            {
              "url": "",
              "title": "Supplier Transparency - OraSure Technologies",
              "snippet": "This statement is made in accordance with, and relates to the fiscal year ended December 31, 2023 and includes the activities of OraSure Technologies, Inc. (\"OraSure\") and its wholly-owned subsidiaries, DNA Genotek Inc. (\"DNAG\"), Diversigen, Inc. (\"Diversigen\") and Novosanis N.V. (\"Novosanis\") (collectively the \"Company\").",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:05.803305+00:00",
              "published_date": null,
              "source_hash": "56eaf26087278312f658baef7bdd687d"
            },
            {
              "url": "",
              "title": "OraSure Technologies Inc (OSUR) Reports Q4 Revenue Decline Amidst ...",
              "snippet": "OraSure Technologies Inc (NASDAQ:OSUR) released its 8-K filing on February 27, 2024, revealing a mixed financial performance for the fourth quarter of 2023. The company, known for its medical ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:05.803316+00:00",
              "published_date": null,
              "source_hash": "fb17e11d3bd6f7b13f3e2a38c017866a"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Secures Strategic Distribution Rights and ...",
              "snippet": "OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company OraSure Technologies, Inc. Thu, Jan 4, 2024, 7:05 AM 8 min ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:05.803325+00:00",
              "published_date": null,
              "source_hash": "9c914a14ad4f2581424c7b61b4a2b92c"
            },
            {
              "url": "",
              "title": "In the News - OraSure Technologies",
              "snippet": "See the latest headlines and read the most recent stories that have featured the OraSure family of companies.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:05.803335+00:00",
              "published_date": null,
              "source_hash": "1e5f3520a8841d84bcee3fbba9ef7100"
            },
            {
              "url": "",
              "title": "Files taken from Orasure systems in cybersecurity incident",
              "snippet": "Orasure believes it has contained the incident and \"preserved the integrity of its core financial and operational systems.\" ... Orasure Technologies said Friday that an unauthorized third party gained access to its data at the end of March. Certain files were taken, and the diagnostic company was investigating the extent of any sensitive ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:05.803345+00:00",
              "published_date": null,
              "source_hash": "3088c259cfea0b7ff539005d61af9abb"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Expands Diagnostic Portfolio with Acquisition of Sherlock Biosciences, Inc.",
              "snippet": "OraSure Technologies, Inc. has announced the acquisition of ... (\"COVID-19\") pandemic on the Company's business, supply chain, labor force, ability to successfully develop new products ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:08.257715+00:00",
              "published_date": "2024-12-19T21:11:00+00:00",
              "source_hash": "83ec4f85ee1771614cd07c1980bcb5bd"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc. Receives $7.5 Million Award for Development of Rapid Antigen Test for Marburg Virus Disease",
              "snippet": "OraSure Technologies received a $7.5 million contract to develop a rapid antigen test for Marburg Virus Disease. OraSure Technologies, Inc. announced ... OraSure's business, supply chain, labor ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:08.257749+00:00",
              "published_date": "2024-12-02T12:11:00+00:00",
              "source_hash": "87b29709328a701e40bc8e4f05f91eb5"
            },
            {
              "url": "",
              "title": "OraSure Technologies, Inc.: OraSure Technologies Acquires Sherlock Biosciences",
              "snippet": "About OraSure Technologies, Inc. OraSure Technologies, Inc. (\"OraSure\") transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:08.257775+00:00",
              "published_date": "2024-12-19T22:06:00+00:00",
              "source_hash": "f72ddfb87d7bc2d802d272a7ed4e5d40"
            },
            {
              "url": "",
              "title": "OraSure: Q3 Earnings Snapshot",
              "snippet": "BETHLEHEM, Pa. (AP) \u2014 BETHLEHEM, Pa. (AP) \u2014 OraSure Technologies Inc. (OSUR) on Wednesday reported a loss of $4.5 million in its third quarter. On a per-share basis, the Bethlehem ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "OraSure Technologies Inc OraSure Technologies Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:42:08.257798+00:00",
              "published_date": "2024-11-06T00:00:00+00:00",
              "source_hash": "4b302104aa709cc7cb48235bb473ffe7"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "OraSure Technologies Inc regulatory challenges FDA",
              "rationale": "Investigate potential legal and regulatory hurdles in product approvals",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "OraSure Technologies Inc rapid diagnostic tests accuracy controversy",
              "rationale": "Explore ethical concerns regarding the accuracy and accessibility of rapid tests in resource-limited settings",
              "priority": 2
            },
            {
              "category": "financial_legal",
              "query": "OraSure Technologies Inc supply chain disruptions",
              "rationale": "Assess risks related to dependency on third-party suppliers and potential supply chain vulnerabilities",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T08:42:26.360264",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}